Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Best of JAAD - Cognitive Bias and Clinical Insights in Dermatology

Description

During a presentation on cognitive bias in dermatology, the speaker discussed how filtering out irrelevant information can lead to diagnostic errors, illustrated by a study where expert radiologists missed a gorilla in radiographs because they were focused solely on tumors. The need for careful scrutiny in inflammatory myopathy screenings was emphasized, with evidence suggesting a third of tests may miss critical antibodies indicative of cancer or lung disease. Other topics included treatment strategies for refractory dermatomyositis, where newer agents like JAK inhibitors show better compliance and outcomes. The efficacy of micro needling to enhance topical treatment delivery was also highlighted. The discussion transitioned to addressing complex dermatological conditions, emphasizing innovative therapies like hyaluronidase for scleroderma-related oral aperture improvement and painless options like non-thermal atmospheric plasma. Additionally, the integration of new biologics and alternative treatments for advanced skin cancers, such as itraconazole, was presented along with specific cautions regarding biologic use in patients with hepatitis. The event concluded by recommending curettage combined with cryotherapy for basal cell carcinoma treatments over traditional electro desiccation, fostering discussions on novel therapeutic approaches and practical advice for managing various dermatologic conditions that impact patient quality of life.

View more

Conclusions

  • Cognitive bias and inattentional blindness significantly contribute to diagnostic errors in medicine.
  • Effective screening for antibodies in patients with inflammatory myopathies is crucial for identifying cancer risks and other complications.
  • Dupilumab offers better outcomes and adherence for the treatment of moderate-to-severe atopic dermatitis in children compared to traditional therapies.
  • Microneedle delivery for betamethasone in alopecia areata provides a less painful alternative to intralesional injections.
  • Baricitinib down-titration in severe alopecia areata maintains response in over half of patients.
  • Hyaluronidase treatment improves microstomia in scleroderma patients with good tolerability.
  • Nonthermal atmospheric plasma is an effective and well-tolerated treatment for wart lesions in pediatric patients.
  • Emerging therapies like cemiplimab and vunakizumab show promising results for treating advanced skin cancers and chronic plaque psoriasis, respectively.
  • Curettage combined with cryotherapy effectively manages non-melanoma skin cancers with low recurrence rates.
  • Continuing medical education Volume 92, Issue 2p213-220February 2025
  • Volume 92, Issue 2p233-234February 2025
  • Volume 92, Issue 2p242-251February 2025
  • Volume 92, Issue 2p269-275February 2025
  • Volume 92, Issue 2p299-306February 2025
  • Volume 91, Issue 6p1207-1208December 2024